Role of the primary care provider in the diagnosis and management of heartburn

@article{Kushner2010RoleOT,
  title={Role of the primary care provider in the diagnosis and management of heartburn},
  author={Pamela R. Kushner},
  journal={Current Medical Research and Opinion},
  year={2010},
  volume={26},
  pages={759 - 765}
}
  • P. Kushner
  • Published 15 March 2010
  • Medicine
  • Current Medical Research and Opinion
Abstract Background: Heartburn affects an estimated 42% of the US population. Often, patients are able to recognize symptoms and self-treat heartburn; however, patients with more persistent and/or troublesome symptoms should be evaluated by a physician or other healthcare provider. Scope: This review focuses on the role of the primary care provider in the diagnosis and treatment of heartburn. Methods: A search was conducted on PubMed (to November 2009) and articles relevant to the management of… 

Randomized clinical trial: Randomized, controlled, single-blind, three-way crossover study to evaluate the efficacy and safety of a new preparation for post- prandial heartburn

TLDR
Reduflux chewable tablet and liquid sachet were efficacious in the treatment of post-prandial heartburn, providing a quick onset and a long duration of action, with sustained symptoms relief in 97% of the subjects.

Histamine-2 Receptor Antagonists and Semen Quality.

  • S. Banihani
  • Biology, Medicine
    Basic & clinical pharmacology & toxicology
  • 2016
TLDR
Cimetidine appears to have adverse effects on semen quality, while ranitidine and nizatidine are still controversial, and famotidine does not appear to change semen quality.

References

SHOWING 1-10 OF 54 REFERENCES

Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life.

TLDR
The prevalence of UGIS in the general population is high and symptoms are associated with significant health-care utilization and poorer quality of life.

What the physician needs to know for correct management of gastro‐oesophageal reflux disease and dyspepsia

  • N. Talley
  • Medicine
    Alimentary pharmacology & therapeutics
  • 2004
Upper gastrointestinal symptoms are highly prevalent; usually those consulting have multiple symptoms, confounding management. Here, common clinically relevant management issues are considered based

Proton Pump Inhibitors: Effective First-Line Treatment for Management of Dyspepsia

TLDR
Empiric PPI treatment would be expected to provide symptom relief to the majority of dyspepsia sufferer who present in clinical practice and should be considered the first-line management approach in patients with uninvestigated dyspeptic patients.

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

TLDR
Guidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) were published in 1995 and updated in 1999 and a discussion of the rare patient with refractory GERD is discussed.

Is it worthwhile performing a PPI trial in primary-care patients with GERD symptoms?

  • P. Katz
  • Medicine
    Nature Clinical Practice Gastroenterology &Hepatology
  • 2007
TLDR
This prospective study included patients in primary care with reflux symptoms that were suggestive of GERD, and the Likert scale was used to assess the frequency and severity of symptoms at baseline.

Guidelines for the Management of Dyspepsia

Dyspepsia is a chronic or recurrent pain or discomfort centered in the upper abdomen; patients with predominant or frequent (more than once a week) heartburn or acid regurgitation, should be

Interventions for heartburn in pregnancy.

TLDR
A range of interventions have been used to relieve symptoms including advice on diet and lifestyle, antacids, antihistamines, and proton pump inhibitors, but the safety and effectiveness of these interventions to relieve heartburn in pregnancy have not been established.

Selection of Drugs to Treat Gastro-Oesophageal Reflux Disease

TLDR
Gastro-oesophageal reflux disease is probably the most common acid-peptic disease in Western countries, and the successful treatment of mild to moderate disease with pharmacotherapy has become commonplace, so cost, adverse effects and drug interactions have become important.
...